Quigley Corp., Doylestown, said today it will collaborate with the Israeli Ministry of Agriculture and Rural Development and Kimron Veterinary Institute to test Quigley compound QR-441 against avian influenza strain H5N1 in chickens.

Quigley said QR-441 will be added to the feed or water of one-week-old chickens who will be exposed to avian influenza. The birds will be checked for signs of illness or death.

Shares were up 7 cents, or 0.90 percent, to $7.85 in midday trading on the Nasdaq.